DJIA 15,291.39 -3.11 -0.02%
NASDAQ 3,449.32 -10.10 -0.29%
S&P 500 1,645.84 -4.67 -0.28%

MannKind Corp

NASDAQ: MNKD

6.53 -0.33 (-4.74%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MNKD $6.52 -4.89%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.78
Previous Close $6.85
Daily Range $6.26 - $6.78
52-Week Range $1.65 - $6.99
Market Cap $1.9B
P/E Ratio -8.35
Dividend (Yield) $0.00 (0.0%)
Volume 12,747,614
Average Daily Volume 6,568,419
Current FY EPS -$0.49

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

MannKind's Run to Glory

But where will this stock's run end?

4 Hot Stocks to Trade (or Not)

Commit To Buy MannKind Corp At $2.50, Earn 28%

Arena Buyout More 'Highly Probable' Than MannKind

The Coming Diabetes Wars

A major battle looms as leading insulin products lose patent protection. Here are the likely winners and losers of the coming diabetes wars.

MannKind's Afrezza And The Oramed Threat

Mid-Afternoon Market Update: MannKind Posts Huge Rally as Markets Plummet

Pricing A Highly Probable Takeover Of MannKind

Oramed Sweeps Past Worldwide Giants With The First Trial Of Orally Delivered Insulin

5 of Last Week's Biggest Winners

These five companies posted double-digit gains this past week.

See More MNKD News...

MNKD's Top Competitors

MNKD $6.53 (-4.74%)
Current stock: MNKD
AMGN $105.43 (-0.18%)
Current stock: AMGN
GILD $55.54 (0.11%)
Current stock: GILD
BIIB $234.54 (0.83%)
Current stock: BIIB